168 related articles for article (PubMed ID: 32949992)
1. Glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
Das A; Khurshid S; Hayat S; Ahmed R; Islam Z
J Neuroimmunol; 2020 Nov; 348():577388. PubMed ID: 32949992
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.
Dekker MJ; van den Akker EL; Koper JW; Manenschijn L; Geleijns K; Ruts L; van Rijs W; Tio-Gillen AP; van Doorn PA; Lamberts SW; Jacobs BC
J Peripher Nerv Syst; 2009 Jun; 14(2):75-83. PubMed ID: 19691529
[TBL] [Abstract][Full Text] [Related]
3. A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.
van Winsen LM; Manenschijn L; van Rossum EF; Crusius JB; Koper JW; Polman CH; Uitdehaag BM
J Clin Endocrinol Metab; 2009 Jun; 94(6):2110-4. PubMed ID: 19318444
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen-DQB1 polymorphisms and haplotype patterns in Guillain-Barré syndrome.
Hayat S; Jahan I; Das A; Hassan Z; Howlader ZH; Mahmud I; Deen Mohammad Q; Islam Z
Ann Clin Transl Neurol; 2019 Sep; 6(9):1849-1857. PubMed ID: 31469245
[TBL] [Abstract][Full Text] [Related]
5. Fc-gamma IIIa-V158F receptor polymorphism contributes to the severity of Guillain-Barré syndrome.
Hayat S; Babu G; Das A; Howlader ZH; Mahmud I; Islam Z
Ann Clin Transl Neurol; 2020 Jun; 7(6):1040-1049. PubMed ID: 32484314
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.
Quax RA; Koper JW; Huisman AM; Weel A; Hazes JM; Lamberts SW; Feelders RA
Rheumatol Int; 2015 Aug; 35(8):1325-33. PubMed ID: 25724472
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 promoter polymorphisms and haplotypes in patients with Guillain-Barré syndrome.
Hayat S; Asad A; Munni MA; Nayeem MAJ; Mostafa MG; Jahan I; Howlader MZH; Mohammad QD; Islam Z
Ann Clin Transl Neurol; 2024 Jan; 11(1):133-142. PubMed ID: 37955408
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barré syndrome in Bangladesh.
Jahan I; Ahammad RU; Farzana KS; Khalid MM; Islam MB; Rahman MI; Nahar S; Kabir Y; Mohmmad QD; Islam Z
J Neuroimmunol; 2017 Sep; 310():46-50. PubMed ID: 28778444
[TBL] [Abstract][Full Text] [Related]
9. CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barré syndrome in the Bangladeshi population.
Rahman MI; Jahan I; Khalid MM; Jahan I; Ahammad RU; Nahar S; Islam Z
J Neuroimmunol; 2018 Jan; 314():8-12. PubMed ID: 29301656
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid and mineralocorticoid receptor polymorphisms and recurrence of major depressive disorder.
Hardeveld F; Spijker J; Peyrot WJ; de Graaf R; Hendriks SM; Nolen WA; Penninx BW; Beekman AT
Psychoneuroendocrinology; 2015 May; 55():154-63. PubMed ID: 25765757
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis.
van Oosten MJ; Dolhain RJ; Koper JW; van Rossum EF; Emonts M; Han KH; Wouters JM; Hazes JM; Lamberts SW; Feelders RA
Arthritis Res Ther; 2010; 12(4):R159. PubMed ID: 20727199
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome.
Roerink SH; Wagenmakers MA; Smit JW; van Rossum EF; Netea-Maier RT; Plantinga TS; Hermus AR
Endocrine; 2016 Jul; 53(1):63-70. PubMed ID: 26873309
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.
Kuijf ML; Geleijns K; Ennaji N; van Rijs W; van Doorn PA; Jacobs BC
J Neuroimmunol; 2008 Dec; 205(1-2):110-2. PubMed ID: 18838176
[TBL] [Abstract][Full Text] [Related]
14. Genetic and in vivo determinants of glucocorticoid sensitivity in relation to clinical outcome of childhood nephrotic syndrome.
Teeninga N; Kist-van Holthe JE; van den Akker EL; Kersten MC; Boersma E; Krabbe HG; Knoers NV; van der Heijden AJ; Koper JW; Nauta J
Kidney Int; 2014 Jun; 85(6):1444-53. PubMed ID: 24429396
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid receptor haplotype and metabolic syndrome: the Lifelines cohort study.
Wester VL; Koper JW; van den Akker EL; Franco OH; Stolk RP; van Rossum EF
Eur J Endocrinol; 2016 Dec; 175(6):645-651. PubMed ID: 27634941
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barré syndrome.
Hayat S; Asad A; Hasan I; Jahan I; Papri N; Howlader ZH; Islam Z
Acta Neurol Scand; 2022 Aug; 146(2):177-185. PubMed ID: 35652365
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition.
van Rossum EF; Lamberts SW
Recent Prog Horm Res; 2004; 59():333-57. PubMed ID: 14749509
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain-Barré syndrome.
Liu H; Xing Y; Guo Y; Liu P; Zhang H; Xue B; Shou J; Qian J; Peng J; Wang R; Gao Y; Fang S
J Neurol Sci; 2016 Oct; 369():39-42. PubMed ID: 27653862
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome.
Myhr KM; Vågnes KS; Marøy TH; Aarseth JH; Nyland HI; Vedeler CA
J Neuroimmunol; 2003 Jun; 139(1-2):81-3. PubMed ID: 12799024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
